Vitamins and Minerals Market in Brazil to 2014 (OTC Healthcare)

Datamonitor, February 2011, Pages: 27

Introduction

This databook provides key data and information on the Vitamins and Minerals Market in Brazil (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.

Scope

-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008

Highlights

The vitamins and minerals category was valued at BRL1,357.8m ($740.4m) in 2009, representing a CAGR of 8.3% since 2004.

By the end of 2014, the vitamins and minerals category will be worth BRL1,802m ($982.7m), with an expected CAGR of 5.8% between 2009 and 2014.

The vitamins and minerals market was led by multi-vitamins (representing 44.7% of the total value) followed by single vitamins and single minerals, with a 21.8% and 20.2% market share, respectively. Tonics accounts for the remaining 13.4% share.

Abbott Laboratories is the market leader with a 51.9% share of the market.

Reasons to Purchase

-Develop business strategies by understanding the quantitative trends within the Vitamins and Minerals Market in Brazil (OTC Healthcare)

-Design effective marketing and sales strategies by identifying key market categories and segments

-Identify key players within the market to plan lucrative M&A, partnerships and agreements

Chapter 1 Executive Summary
Summary category level: vitamins and minerals

Chapter 2 Definition

Chapter 3 Category Analysis: Vitamins and Minerals
Value analysis (Brazilian Real), 2004-09
Value analysis (Brazilian Real), 2009-14
Value analysis (US dollars), 2004-09
Value analysis (US dollars), 2009-14
Company and brand share analysis
Distribution analysis

Chapter 4 Macroeconomic Profile
Macroeconomic Indicators

Chapter 5 Research Methodology
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research

LIST OF FIGURES
Figure 1: Vitamins and minerals, Brazil, value by segment (BRLm), 2004-14
Figure 2: Vitamins and minerals, Brazil, category growth comparison, by value, 2004-14
Figure 3: Vitamins and minerals, Brazil, company share by value (%), 2008-09
Figure 4: Vitamins and minerals, Brazil, distribution channels by value (%), 2008-09
Figure 5: Annual data review process

LIST OF TABLES
Table 1: Vitamins and minerals category definitions
Table 2: Vitamins and minerals distribution channels
Table 3: Vitamins and minerals, Brazil, value by segment (BRLm), 2004-09
Table 4: Vitamins and minerals, Brazil, value forecast by segment (BRLm), 2009-14
Table 5: Vitamins and minerals, Brazil, value by segment ($m), 2004-09
Table 6: Vitamins and minerals, Brazil, value forecast by segment ($m), 2009-14
Table 7: Vitamins and minerals, Brazil, brand share by value (%), 2008-09
Table 8: Vitamins and minerals, Brazil, value by brand (BRLm), 2008-09
Table 9: Vitamins and minerals, Brazil, company share by value (%), 2008-09
Table 10: Vitamins and minerals, Brazil, value by company (BRLm), 2008-09
Table 11: Vitamins and minerals, Brazil, distribution channels by value (%), 2008-09
Table 12: Vitamins and minerals, Brazil, value by distribution channel (BRLm), 2008-09
Table 13: Brazil population, by age group, 2004-09 (millions)
Table 14: Brazil population forecast, by age group, 2009-14 (millions)
Table 15: Brazil population, by gender, 2004-09 (millions)
Table 16: Brazil population forecast, by gender, 2009-14 (millions)
Table 17: Brazil nominal GDP, 2004-09 (BRLbn, nominal prices)
Table 18: Brazil nominal GDP forecast, 2009-14 (BRLbn, nominal prices)
Table 19: Brazil real GDP, 2004-09 (BRLbn, 2000 prices)
Table 20: Brazil real GDP forecast, 2009-14 (BRLbn, 2000 prices)
Table 21: Brazil real GDP, 2004-09 ($bn, 2000 prices)
Table 22: Brazil real GDP forecast, 2009-14 ($bn, 2000 prices)
Table 23: Brazil consumer price index, 2004-09 (2000=100)
Table 24: Brazil consumer price index, 2009-14 (2000=100)

Customers who bought this item also bought

• Emerging Market for Clinical Trials in Brazil - Improved Guidelines from ANVISA and CONEP are Shortening the Regulatory Approval Process and Advancing the Market
• Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing
• Nutraceuticals Product Market: Latin America Market Size, Segment And Country Analysis And Forecasts (2007-2017)
• Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs
• Healthcare, Regulatory and Reimbursement Landscape - Brazil
• Biologics Market in Brazil
• Market Access Brazil: Unlocking Pharma Potential.
• Brazil Diabetes Market Report & Forecast 2011-2016
• Opportunities in Emerging Markets - Latin America, Brazil, and Mexico
• Brazil Pharmaceutical Market Overview - Expanding healthcare access drives double-digit sales growth